Comparative Risk of Venous Thromboembolism in Rheumatoid Arthritis Patients Receiving Tofacitinib Versus Those Receiving Tumor Necrosis Factor Inhibitors: An Observational Cohort Study
2018 ◽
Vol 79
(1)
◽
pp. 60-68
◽
2017 ◽
2018 ◽
Vol 7
(3)
◽